Nature Communications (Feb 2023)

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity

  • Wei-Hung Chen,
  • Agnes Hajduczki,
  • Elizabeth J. Martinez,
  • Hongjun Bai,
  • Hanover Matz,
  • Thomas M. Hill,
  • Eric Lewitus,
  • William C. Chang,
  • Layla Dawit,
  • Caroline E. Peterson,
  • Phyllis A. Rees,
  • Adelola B. Ajayi,
  • Emily S. Golub,
  • Isabella Swafford,
  • Vincent Dussupt,
  • Sapna David,
  • Sandra V. Mayer,
  • Sandrine Soman,
  • Caitlin Kuklis,
  • Courtney Corbitt,
  • Jocelyn King,
  • Misook Choe,
  • Rajeshwer S. Sankhala,
  • Paul V. Thomas,
  • Michelle Zemil,
  • Lindsay Wieczorek,
  • Tricia Hart,
  • Debora Duso,
  • Larry Kummer,
  • Lianying Yan,
  • Spencer L. Sterling,
  • Eric D. Laing,
  • Christopher C. Broder,
  • Jazmean K. Williams,
  • Edgar Davidson,
  • Benjamin J. Doranz,
  • Shelly J. Krebs,
  • Victoria R. Polonis,
  • Dominic Paquin-Proulx,
  • Morgane Rolland,
  • William W. Reiley,
  • Gregory D. Gromowski,
  • Kayvon Modjarrad,
  • Helen Dooley,
  • M. Gordon Joyce

DOI
https://doi.org/10.1038/s41467-023-36106-x
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 18

Abstract

Read online

SARS-CoV-2 variants of concern continue to emerge, reducing vaccine efficacy and limiting therapeutic options. Here, Chen and colleagues describe the identification and design of shark nanobodies with pansarbecovirus activity.